Detection of Cyclin B1 Expression in G1-Phase Cancer Cell Lines and Cancer Tissues by Postsorting Western Blot Analysis

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1607-1610

  Shen, Manli ^a   Feng, Yongdong ^a   Gao, Chun ^a   Tao, Deding ^a   Hu, Junbo ^a   Reed, Eddie ^b   Li, Qingdi Q ^b   Gong, Jianping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN B;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL SELECTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA; MITOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CHEMISTRY; FEMALE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIN B; FEMALE; G1 PHASE; HUMANS; MICROSCOPY, CONFOCAL; NEOPLASMS;

EID: 1642277781     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3321     Document Type: Article

References (18)

1. Wikson, E. B. The cell in development and heredity, 3rd Ed. Macmillan, New York, 1995.
2. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell, 79: 547-550, 1994.
3. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
4. Norbury, C., and Nurse, P. Animal cell cycles and their control. Trends. Biochem. Sci., 19: 143-145, 1992.
5. Lehner, C. F., and O'Farrell, P. H. The roles of Drosophila cyclins A and B in mitotic control. Cell, 61: 535-547, 1990.
6. Pines, J. M., and Hunter, T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell, 58: 833-846, 1989.
7. Pines, J., and Hunter, T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell Biol., 115: 1-17, 1991.
8. Gong, J., Traganos, F., and Darzynkiewicz, Z. Growth imbalance and altered expression of cyclins B1, A., E and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth Differ., 6: 1485-1493, 1995.
9. Gong, J., Ardelt, B., Traganos, F., and Darzynkiewica, Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res., 54: 4285-4288, 1994.
10. Villard, J. F., Lacombe, F., Dupouy, M., Ferry, H., Belloc, F., and Reiffers, J. Flow cytometry study of human cyclin B1 and cyclin E expression in leukemic cell lines: cell cycle kinetics and cell localization. Exp. Cell Res., 247: 208-219, 1999.
11. Villard, J. F., Lacombe, F., Dupouy, M., Ferry, H., Belloc, F., and Reiffers, J. Different expression profile of human cyclin B1 in normal PHA-stimulated T lymphocytes and leukemic T cells. Cytometry, 39: 117-125, 2000.
12. Gong, J., Traganos, F., and Darzynkiewicz, Z. Expression of cyclins B and E in individual MOLT-4 cells and in stimulated human lymphocytes during their progression through the cell cycle. Int. J. Oncol., 3: 1037-1042, 1993.
13. Qin, J., Tao, D., Li, Q. Q., Hu, J., and Gong, J. Cytokinetic analysis of cell cycle and sub-phases in MOLT-4 cells by cyclin E+A/DNA multiparameter flow cytometry. Oncol. Rep., 9: 1041-1045, 2002.
14. Yamashita, K., Yasuda, H., Pines, J., Nishitani, H., Ohtsubo, M., Hunter, T., Sugimura, T., and Nishimoto, T. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells. EMBO J., 9: 4331-4338, 1990.
15. Keyonarsi, K., and Pardee, A. P. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA, 90: 1112-1116, 1993.
16. Ito, Y., Takeda, T., Sakon, M., Monden, M., Tsujimoto, M., and Matsuura, N. Expression and prognostic role of cyclin-dependent protein kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 59: 68-74, 2000.
17. Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W., and Greenberg, A. H. Premature p34cdc2 activation required for apoptosis. Science (Wash. DC) 263: 1143-1145, 1994.
18. Meikrantz, W., and Schlegel, R. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J. Biol. Chem., 271: 10205-10209, 1996.